1. Targeted delivery of doxorubicin to cancer cells by a cruciform DNA nanostructure composed of AS1411 and FOXM1 aptamers;Abnous;Expet Opin. Drug Deliv,2018
2. Metastasis-free interval in breast cancer patients: thirty-year trends and time dependency of prognostic factors. A retrospective analysis based on a single institution experience;de l'Aulnoit,2018
3. A history of cancer chemotherapy;DeVita,2008
4. M.W.S.C.J.J.o.t.N.C. Institute, Breast cancer risk in relation to the interval between menopause and starting hormone therapy;Beral,2011
5. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial;James,2016